Genetic Signatures features in AusBiotech ’30 success stories in 30 days’

AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy. AusBiotech marked 30 years since the industry organisation was founded on 28 December 2015. As part of the 2016 celebrations of this event, the organisation is publishing ’30 success stories in 30 days’ in February, showcasing the impressive achievements of Australia’s biotechnology industry

Genetic Signatures was featured as part of these Australian Biotechnology industry success stories.

30 success stories: Genetic Signatures (20/30)

20 February 2016: Australian-born Genetic Signatures made its successful IPO on the ASX last year, further enabling its life-saving work with molecular tools to screen for a wide array of infectious pathogens.

Genetic Signatures, or Human Genetic Signatures as it was originally known, was co-founded by the late Dr Geoffrey Grigg and Mr Chris Abbott in 2001.

Both masters in their respective fields, Dr Grigg was a prolific Australian scientist and former division chief at the CSIRO with an exceptional ability to exploit opportunities in both research and biotechnology, whilst Mr Abbott was a highly regarded businessman who co-founded the investment firm Maple-Brown Abbott. However what drew the two men together was their deep held interest and belief in the potential of the Australian biotech market. read more…